The Centers for Disease Control and Prevention (CDC), an agency within the U.S. Department of Health and Human Services, oversees this funding opportunity under its Extramural Research Administration (ERA) division. With a commitment to safeguarding public health, the CDC funds programs and research that aim to prevent disease, injury, and disability in both the U.S. and global populations.
This grant opportunity, issued under RFA-GH-18-000, is structured as a Cooperative Agreement and falls under the injury prevention and control category (Assistance Listing 93.136). It is a discretionary funding opportunity intended to support health-focused initiatives. The CDC aims to fund up to 100 recipients through this grant. While the detailed program objectives are not included in the current synopsis, the nature of the agency and its listing suggest a focus on applied health research, capacity building, and public health system strengthening. The agency encourages submissions from a wide array of applicants including state entities, academic institutions, local governments, nonprofit organizations, and small businesses.
Applicants should be prepared to submit full applications directly via Grants.gov. While no pre-application steps such as letters of intent or concept notes are specified, the final deadline for submission is September 30, 2030, indicating a long open window for potential applicants. The original deadline was October 13, 2025, hinting at the potential for multiple evaluation phases or rolling cohorts. However, no specific application components, review criteria, or required attachments are outlined in the provided synopsis.
There is no cost sharing or matching requirement for this opportunity. Additionally, the estimated total program funding, as well as award floor and ceiling values, have not been published at this time. As such, applicants should verify budgetary limits and consult directly with the agency or wait for a full NOFO release for specific details.
The primary contact for this grant is Linton C. Browning, a Grants Management Specialist with the CDC, who can be reached via email at lbrowning@cdc.gov or by phone at 770-488-2756. Applicants experiencing difficulty accessing the announcement online are encouraged to contact Mr. Browning directly.
Given the open-ended application window and unspecified financial scope, this grant appears to recur or accept rolling submissions, although the details suggest a final deadline rather than continuous acceptance. Applicants should prepare accordingly and seek additional clarifications from the agency to ensure full compliance with all future updates or complete announcements.
